Search Within

DIABETIC NEPHROPATHIES

The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy

Journal: Current Clinical Pharmacology
Volume: 14, Issue: 2
Page: 78-83
Authors: Luxitaa Goenka, Raghavan Padmanaban and Melvin George*

Renin–Angiotensin–Aldosterone System Gene Polymorphisms and Type 2 Diabetic Nephropathy in Asian Populations: An Updated Meta-analysis

Journal: Current Diabetes Reviews
Volume: 15, Issue: 4
Page: 263-276
Authors: Norfazilah Ahmad, Rahman Jamal *, Shamsul Azhar Shah, Abdul Halim Abdul Gafor and Nor Azian Abdul Murad

Glycation and HMG-CoA Reductase Inhibitors: Implication in Diabetes and Associated Complications

Journal: Current Diabetes Reviews
Volume: 15, Issue: 3
Page: 213-223
Authors: Rabia Nabi, Sahir Sultan Alvi, Mohd. Saeed, Saheem Ahmad and Mohammad Salman Khan*

Vascular Calcification and not Arrhythmia in Idiopathic Atrial Fibrillation Associates with Sex Differences in Diabetic Microvascular Injury miRNA Profiles

Journal: MicroRNA
Volume: 8, Issue: 2
Page: 127-134
Authors: Elton Dudink*, Barend Florijn, Bob Weijs, Jacques Duijs, Justin Luermans, Frederique Peeters, Leon Schurgers, Joachim Wildberger, Ulrich Schotten, Roel Bijkerk, Harry J. Crijns and Anton Jan van Zonneveld

Early Occurrence Cases of Diabetes Mellitus: Clinical Picture in Two Major Tertiary Care Hospitals in India

Journal: Current Diabetes Reviews
Volume: 15, Issue: 2
Page: 141-148
Authors: Nitin Joseph*, Shreya Sharma, Vinisha Modi, Sanath Manjunatha, Saad A. Siddiqui and Mihika Sinha

Therapeutic Potential of DNA-aptamers Raised Against AGE-RAGE Axis in Diabetes-related Complications

Journal: Current Pharmaceutical Design
Volume: 24, Issue: 24
Page: 2802-2809
Authors: Sho-ichi Yamagishi* and Takanori Matsui

Drosophila Renal Organ as a Model for Identification of Targets and Screening of Potential Therapeutic Agents for Diabetic Nephropathy

Journal: Current Drug Targets
Volume: 19, Issue: 16
Page: 1980-1990
Authors: Lavi Rani and Naveen Kumar Gautam*

Interferon-λ3 as a Predictor of Survival in Hemodialysis Patients.

Journal: Current Molecular Medicine
Volume: 18, Issue: 4
Page: 207-215
Authors: A.E. Grzegorzewska*, M.K. Swiderska and W. Warchol

M1/M2 Macrophages in Diabetic Nephropathy: Nrf2/HO-1 as Therapeutic Targets

Journal: Current Pharmaceutical Design
Volume: 24, Issue: 20
Page: 2241-2249
Authors: Robert Clive Landis*, Kim R. Quimby and Andre R. Greenidge

Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs

Journal: MicroRNA
Volume: 7, Issue: 3
Page: 178-186
Authors: Andrea Conte and Giovanna Maria Pierantoni*

Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 27
Page: 3256-3271
Authors: Shikun Yang, Aimei Li, JianWen Wang, Jun Liu, Yachun Han, Wei Zhang, Yan Chun Li and Hao Zhang*

Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy

Journal: Current Diabetes Reviews
Volume: 14, Issue: 5
Page: 481-486
Authors: Salah Shelbaya, Manal Mohamed Abu Shady*, Merhan Samy Nasr, Meram Mohamed Bekhet, Yasmine Abd-Al Mageed and Magdy Abbas

Urotensin II: Molecular Mechanisms of Biological Activity

Journal: Current Protein & Peptide Science
Volume: 19, Issue: 9
Page: 924-934
Authors: Andrey A. Svistunov, Vadim V. Tarasov, Svetlana A. Shakhmardanova, Susanna S. Sologova, Ekaterina T. Bagaturiya, Vladimir N. Chubarev, Pavel A. Galenko-Yaroshevsky, Marco Fidel Avila-Rodriguez, George E. Barreto and Gjumrakch Aliev*

Urinary Exosomal Lipidomics Reveals Markers for Diabetic Nephropathy

Journal: Current Metabolomics
Volume: 6, Issue: 2
Page: 131-139
Authors: Sangeeta Kumari* and Ajeet Singh

Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18, Issue: 2
Page: 120-126
Authors: Konstantinos Stavropoulos*, Konstantinos P. Imprialos, Nikiforos Stavropoulos, Sofia Bouloukou, Georgios Kerpiniotis, Kyriakos Dimitriadis, Constantinos Tsioufis and Michael Doumas

Sodium-glucose Cotransporter 2 Inhibitors: Potential Cardiovascular and Mortality Benefits

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18, Issue: 2
Page: 114-119
Authors: Dragan Lovic*, Andreas Pittaras, Manolis Kallistratos, Constantinos Tsioufis, Charalampos Grassos, Dragan Djordjevic, Ivan Tasic and Athanasios Manolis

Role of Matrix Metalloproteinases in Degenerative Kidney Disorders

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 15
Page: 1805-1816
Authors: Shifa Narula, Chanderdeep Tandon and Simran Tandon*

IGF-1R Inhibitor Ameliorates Diabetic Nephropathy with Suppressed HMGN1/TLR4 Pathway

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 18, Issue: 3
Page: 241-250
Authors: Jiali Yu, Jingjing Da, Rong Dong, Yi Sun, Yingjie Nie, Fuxun Yu, Li Zuo and Yan Zha*

The Correlation Between Urinary 8-Iso-Prostaglandin F2α and Hydrogen Peroxide Toward Renal Function in T2DM Patients Consuming Sulfonylurea and Combination of Metformin-Sulfonylurea

Journal: Current Diabetes Reviews
Volume: 14, Issue: 2
Page: 189-195
Authors: Rani Sauriasari*, Fitri Wulandari, Rahmaningtyas Nurifahmi, Andisyah P. Sekar and Veronika Y. Susilo

Serum Levels of Vaspin and Its Correlation with Nitric Oxide in Type 2 Diabetic Patients with Nephropathy

Journal: Current Diabetes Reviews
Volume: 14, Issue: 2
Page: 162-167
Authors: Aynaz Mihanfar, Mohammad Rahmati-Yamchi, Ali Mota, Sima Abediazar, Younes Pilehvar-Soltanahmadi and Nosratollah Zarghami*

Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy

Journal: Current Diabetes Reviews
Volume: 14, Issue: 2
Page: 149-161
Authors: Yuxuan Wang, Chengcheng Wang, Xiuli Zhang, Harvest F. Gu* and Liang Wu*

CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?

Journal: Current Gene Therapy
Volume: 17, Issue: 6
Page: 442-452
Authors: Quan Zhuang, Ke Cheng* and Yingzi Ming*

Antidiabetic Drugs and the Kidney

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 41
Page: 6310-6320
Authors: Vasilis Tsimihodimos*, Nikolaos Karanatsis, Eleftheria Tzavela and Moses Elisaf

Circulating ACE2 in Cardiovascular and Kidney Diseases

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 30
Page: 3231-3241
Authors: L. Anguiano, M. Riera , J. Pascual and M. J. Soler*

Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 31
Page: 3397-3412
Authors: Andreas Eisenreich* and Ulrike Leppert

Traditional Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes Mellitus

Journal: Current Diabetes Reviews
Volume: 13, Issue: 6
Page: 533-543
Authors: Kim Donaghue* and Sze Lyn Jeanne Wong

Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy

Journal: Current Diabetes Reviews
Volume: 13, Issue: 6
Page: 598-605
Authors: Lalit Kishore, Navpreet Kaur and Randhir Singh*

Mitochondria: A Novel Therapeutic Target in Diabetic Nephropathy

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 29
Page: 3185-3202
Authors: Shikun Yang, Yachun Han , Jun Liu , Panai Song , Xiaoxuan Xu, Li Zhao , Chun Hu , Li Xiao , Fuyou Liu , Hao Zhang and Lin Sun *

Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges

Journal: Current Vascular Pharmacology
Volume: 15, Issue: 6
Page: 557-565
Authors: Grigorios G. Dimas*, Triantafyllos P. Didangelos and Dimitrios M. Grekas

Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 17, Issue: 2
Page: 114-124
Authors: Xiaoyu Ma, Li An and Qiuyue Wang*

SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 10
Page: 1510-1521
Authors: Konstantinos Imprialos, Charles Faselis, Chrysoula Boutari, Konstantinos Stavropoulos, Vasilios Athyros, Asterios Karagiannis and Michael Doumas*

Seaweed Polysaccharides - New Therapeutic Insights Against the Inflammatory Response in Diabetic Nephropathy

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 15, Issue: 3
Page: 178-190
Authors: Durairaj Vaishnudevi and Pragasam Viswanathan*

Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges

Journal: Protein & Peptide Letters
Volume: 24, Issue: 1
Page: 71-77
Authors: Heba El Gamal and Shankar Munusamy

The Association of Folic Acid Deficiency and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 16, Issue: 2
Page: 120-123
Authors: Sonny Bherwani, A.S. Saumya, Ashok Kumar Ahirwar, A.S. Sandhya, Brijesh Prajapat, Sitendu Patel, Ritu Singh and L.H. Ghotekar

Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives

Journal: Current Traditional Medicine
Volume: 2, Issue: 1
Page: 59-69
Authors: Qiu-He Chen, Rong-Biao Pi and Jing-Kao Chen

Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

Journal: Current Drug Targets
Volume: 17, Issue: 11
Page: 1252-1264
Authors: Karly C. Sourris, Henry Yao, George Jerums, Mark E.Cooper, Elif I. Ekinci and Melinda T. Coughlan

Targeted Metabolomics Reveals Hippurate as a Urinary Potential Marker for Diabetic Nephropathy

Journal: Current Metabolomics
Volume: 4, Issue: 2
Page: 121-128
Authors: Sangeeta Kumari and Pradeep Sharma

Epigenetic Regulation Through SIRT1 in Podocytes

Journal: Current Hypertension Reviews
Volume: 12, Issue: 2
Page: 89-94
Authors: Yoshihisa Nakatani and Reiko Inagi

A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity

Journal: Current Genomics
Volume: 17, Issue: 3
Page: 279-293
Authors: Zeneida Herrera-Pérez, Norbert Gretz and Harsh Dweep

Diabetic Nephropathy: Focus on Current and Future Therapeutic Strategies

Journal: Current Drug Metabolism
Volume: 17, Issue: 5
Page: 497-502
Authors: Riccardo Pofi, Francesca Di Mario, Antonietta Gigante, Edoardo Rosato, Andrea M. Isidori, Antonio Amoroso, Rosario Cianci and Biagio Barbano

Mitochondrial genome sequencing in atherosclerosis: what's next?

Journal: Current Pharmaceutical Design
Volume: 22, Issue: 3
Page: 390-396
Authors: Margarita A. Sazonova, Tatiana P. Shkurat, Natalya A. Demakova, Andrey V. Zhelankin, Valeria A. Barinova, Igor A. Sobenin and Alexander N. Orekhov

Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy

Journal: Current Medicinal Chemistry
Volume: 22, Issue: 24
Page: 2858-2870
Authors: C. Hu, L. Sun, L. Xiao, Y. Han, X. Fu, X. Xiong, X. Xu, Y. Liu, S. Yang, F. Liu and Y.S. Kanwar

Combination Therapy with Chinese Medicine and ACEI/ARB for the Management of Diabetic Nephropathy: The Promise in Research Fragments

Journal: Current Vascular Pharmacology
Volume: 13, Issue: 4
Page: 526-539
Authors: Xiang Tu, XueFeng Ye, ChunGuang Xie, Jing Chen, Fei Wang and Sen Zhong

Screening for Potential Bioactive Components in Ginkgo biloba Extract by the Rat Renal Tubular Epithelial Cell Extraction and LC-MS/MS

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 18, Issue: 5
Page: 514-523
Authors: Ying Li, Yin-jie Li, Zheng Li, Jing-Ying Qiu, Xiao-Xiao Zheng, Ting-Ting Bian, Feng-Lei Gao, Yan-Yan Yu, Dong-Zhi Yang and Dao-Quan Tang

“PARG Inhibitors’ Success: A Long Way to Go!”

Journal: Current Enzyme Inhibition
Volume: 10, Issue: 2
Page: 81-93
Authors: Anuradha Pandey, Pooja Makhija, Prakash G. Chandak and Anil B. Gaikwad

Mechanisms of Renal Microvascular Dysfunction in Type 1 Diabetes: Potential Contribution to End Organ Damage

Journal: Current Vascular Pharmacology
Volume: 12, Issue: 6
Page: 781-787
Authors: Pamela K. Carmines

A Glimpse of Matrix Metalloproteinases in Diabetic Nephropathy

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 28
Page: 3244-3260
Authors: X. Xu, L. Xiao, P. Xiao, S. Yang, G. Chen, F. Liu, Y.S. Kanwar and L. Sun

Renal Endothelial Dysfunction in Diabetic Nephropathy

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 14, Issue: 1
Page: 22-33
Authors: Huifang Cheng and Raymond C. Harris

Hyperglycemia to Nephropathy via Transforming Growth Factor Beta

Journal: Current Diabetes Reviews
Volume: 10, Issue: 3
Page: 182-189
Authors: Mayuresh Sudamrao Garud and Yogesh Anant Kulkarni

Kinin Receptors in Vascular Biology and Pathology

Journal: Current Vascular Pharmacology
Volume: 12, Issue: 2
Page: 223-248
Authors: Rejean Couture, Nelly Blaes and Jean-Pierre Girolami

Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Diabetic Nephropathy

Journal: Current Drug Targets
Volume: 15, Issue: 5
Page: 531-538
Authors: Mandeep Kumar Arora and Umesh Kumar Singh

Gene Therapy, A Targeted Treatment for Diabetic Nephropathy

Journal: Current Medicinal Chemistry
Volume: 20, Issue: 30
Page: 3774-3784
Authors: X. Lin, L. Tao and D. Tang

Adenosine Receptors: New Therapeutic Targets for Inflammation in Diabetic Nephropathy

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 12, Issue: 3
Page: 153-161
Authors: Nehal M. Elsherbiny and Mohammed M. Al-Gayyar

Combination of Daidzein, Hemin and Bms182874 Halts the Progression of Diabetes-Induced Experimental Nephropathy

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 13, Issue: 2
Page: 152-162
Authors: Taruna Katyal, Arun Garg and R. D. Budhiraja

Angiotensin II Blockade and Renal Protection

Journal: Current Pharmaceutical Design
Volume: 19, Issue: 17
Page: 3033-3042
Authors: Hiroyuki Kobori, Hirohito Mori, Tsutomu Masaki and Akira Nishiyama

Targeting Adenosine Signaling to Treatment of Diabetic Nephropathy

Journal: Current Drug Targets
Volume: 14, Issue: 4
Page: 490-496
Authors: Claudia Quezada, Sebastian Alarcon, Catherinne Jaramillo, Daniel Munoz, Carlos Oyarzun and Rody San Martin

Diabetic Nephropathy: Causes and Managements

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Under Re-organization)
Volume: 7, Issue: 1
Page: 57-64
Authors: Yamini B. Tripathi and Durgavati Yadav

Current Update in the Management of Diabetic Nephropathy

Journal: Current Diabetes Reviews
Volume: 9, Issue: 1
Page: 62-77
Authors: Peter Noel Van Buren and Robert Toto

Biomarkers of Diabetic Nephropathy, the Present and the Future

Journal: Current Diabetes Reviews
Volume: 8, Issue: 5
Page: 317-328
Authors: Belinda Jim, Jolina Santos, Fuad Spath and John Cijiang He

Genetic Association Studies in Diabetic Nephropathy

Journal: Current Diabetes Reviews
Volume: 8, Issue: 5
Page: 336-344
Authors: Harvest F. Gu and Kerstin Brismar

Telmisartan in the Management of Diabetic Nephropathy: A Contemporary View

Journal: Current Diabetes Reviews
Volume: 8, Issue: 3
Page: 183-190
Authors: Pitchai Balakumar, Harish K. Bishnoi and Nanjaian Mahadevan

Impact of Mast Cell Chymase on Renal Disease Progression

Journal: Current Hypertension Reviews
Volume: 8, Issue: 1
Page: 15-23
Authors: Haimanot Wasse, Nawazish Naqvi and Ahsan Husain

Novel Treatments in Diabetic Nephropathy

Journal: Current Hypertension Reviews
Volume: 8, Issue: 1
Page: 71-78
Authors: Usha Panchapakesan and Carol Pollock

Could Additional Inhibitors of the Renin -Angiotensin System be Clinically Useful?

Journal: Current Hypertension Reviews
Volume: 8, Issue: 1
Page: 2-8
Authors: Richard N. Re and Julia L. Cook

The Role of Matrix Metalloproteinases in Diabetes Mellitus

Journal: Current Topics in Medicinal Chemistry
Volume: 12, Issue: 10
Page: 1159-1165
Authors: Costas Tsioufis, Ioannis Bafakis, Alexandros Kasiakogias and Christodoulos Stefanadis

Glucose Transporters in Normal and Diabetic Kidneys

Journal: Current Enzyme Inhibition
Volume: 2, Issue: 3
Page: 305-310
Authors: Charles W. Heilig and Youli Wang

Targeting Plasminogen Activator Inhibitor-1: Role in Cell Signaling and the Biology of Domain-Specific Knock-in Mice

Journal: Current Drug Targets
Volume: 8, Issue: 9
Page: 982-995
Authors: R. D. Balsara, Z. Xu and V. A. Ploplis

Podocytes as a Target of Prorenin in Diabetes

Journal: Current Diabetes Reviews
Volume: 7, Issue: 1
Page: 17-21
Authors: Mariyo Sakoda, Hiroshi Itoh and Atsuhiro Ichihara

Advanced Glycation: How are we Progressing to Combat this Web of Sugar Anomalies in Diabetic Nephropathy

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 27
Page: 3361-3372
Authors: Josephine M. Forbes, Vicki Thallas-Bonke, Mark E. Cooper and Merlin C. Thomas

Role of AGEs in Diabetic Nephropathy

Journal: Current Pharmaceutical Design
Volume: 14, Issue: 10
Page: 946-952
Authors: Kei Fukami, Sho-ichi Yamagishi, Seiji Ueda and Seiya Okuda

Is Inflammation a Common Retinal-Renal-Nerve Pathogenic Link in Diabetes?

Journal: Current Diabetes Reviews
Volume: 6, Issue: 5
Page: 294-303
Authors: Kirti Kaul, Andrea Hodgkinson, Joanna M. Tarr, Eva M. Kohner and Rakesh Chibber

Statin Attenuates High Glucose-Induced and Angiotensin II-Induced MAP Kinase Activity Through Inhibition of NAD(P)H Oxidase Activity in Cultured Mesangial Cells

Journal: Medicinal Chemistry
Volume: 1, Issue: 5
Page: 461-468
Authors: H. Y. Yu, T. Inoguchi, M. Nakayama, H. Tsubouchi, N. Sato, N. Sonoda, S. Sasaki, K. Kobayashi and H. Nawata

Point-of-Care Testing in Diabetes Care

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11, Issue: 2
Page: 178-184
Authors: E. Matteucci and O. Giampietro

3,4-DGE is Important for Side Effects in Peritoneal Dialysis What About its Role in Diabetes

Journal: Current Medicinal Chemistry
Volume: 13, Issue: 22
Page: 2695-2702
Authors: Alberto Ortiz, Anders Wieslander, Torbjorn Linden, Beatriz Santamaria, Ana Sanz, Pilar Justo, Maria-Dolores Sanchez-Nino, Alberto Benito and Per Kjellstrand

The Podocyte: a Potential Therapeutic Target in Diabetic Nephropathy?

Journal: Current Pharmaceutical Design
Volume: 13, Issue: 26
Page: 2713-2720
Authors: Sally M. Marshall

The Reno-Protective Effect of the Dual Blockade of the Renin Angiotensin System (RAS)

Journal: Current Pharmaceutical Design
Volume: 11, Issue: 10
Page: 1291-1300
Authors: Jose Luno, Manuel Praga and Soledad Garcia de Vinuesa

Vasoactive Renal Factors and the Progression of Diabetic Nephropathy

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 27
Page: 3373-3384
Authors: Lesley Wassef, Robyn G. Langham and Darren J. Kelly

Cardiovascular Disease in Patients with Diabetic Nephropathy

Journal: Current Molecular Medicine
Volume: 8, Issue: 6
Page: 533-543
Authors: Yoshimasa Aso

Oxidative Stress in Diabetic Nephropathy

Journal: Current Medicinal Chemistry
Volume: 17, Issue: 34
Page: 4256-4269
Authors: N. Kashihara, Y. Haruna, V. K. Kondeti and Y. S. Kanwar

Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy

Journal: Current Vascular Pharmacology
Volume: 3, Issue: 3
Page: 267-283
Authors: Irina G. Obrosova and Ulrich A. Julius

Pleiotropic Effects of ARB in Diabetes Mellitus

Journal: Current Vascular Pharmacology
Volume: 9, Issue: 2
Page: 136-144
Authors: Shu-ichi Saitoh and Yasuchika Takeishi

Angiotensin I-Converting Enzyme: A Pathogenetic Role in Diabetic Renal Damage?

Journal: Current Diabetes Reviews
Volume: 3, Issue: 1
Page: 41-52
Authors: A. Titia Lely, Peter T. Luik and Gerjan Navis

Role of Nitrosative Stress and Peroxynitrite in the Pathogenesis of Diabetic Complications. Emerging New Therapeutical Strategies

Journal: Current Medicinal Chemistry
Volume: 12, Issue: 3
Page: 267-275
Authors: Pal Pacher, Irina G. Obrosova, Jon G. Mabley and Csaba Szabo

Role of NADPH Oxidase in Hypertension and Diabetic Nephropathy

Journal: Current Hypertension Reviews
Volume: 1, Issue: 1
Page: 15-20
Authors: Maristela L. Onozato and Akihiro Tojo

Lipoproteins and Diabetic Microvascular Complications

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 27
Page: 3395-3418
Authors: A. J. Jenkins, K. G. Rowley, T. J. Lyons, J. D. Best, M. A. Hill and R. L. Klein


Vascular Endothelial Growth Factor (VEGF) in the Pathogenesis of Diabetic Nephropathy of Type 1 Diabetes Mellitus

Journal: Current Drug Targets
Volume: 12, Issue: 1
Page: 107-114
Authors: Maria Mironidou-Tzouveleki, Stergios Tsartsalis and Constantinos Tomos

Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy

Journal: Current Pharmacogenomics
Volume: 2, Issue: 1
Page: 61-74
Authors: M. C. Lansang and N. K. Hollenberg

Aliskiren in Patients with Diabetes: A Systematic Review

Journal: Current Vascular Pharmacology
Volume: 10, Issue: 2
Page: 140-146
Authors: Evangelos C. Rizos, Aris P. Agouridis and Moses S. Elisaf

Diabetes-Induced Alterations in Renal Medullary Microcirculation and Metabolism

Journal: Current Diabetes Reviews
Volume: 3, Issue: 1
Page: 53-65
Authors: Lina Nordquist and Fredrik Palm

Down-Regulation of Angiogenic Inhibitors: A Potential Pathogenic Mechanism for Diabetic Complications

Journal: Current Diabetes Reviews
Volume: 1, Issue: 2
Page: 183-196
Authors: Jian-xing Ma, Sarah X. Zhang and Joshua J. Wang

Renoprotection with Anti-Hypertensives: Reduction of Proteinuria and Improvement of Oxygenation via Inhibition of the Renin-Angiotensin System

Journal: Current Hypertension Reviews
Volume: 1, Issue: 1
Page: 67-76
Authors: Masaomi Nangaku, Takamoto Ohse, Tetsuhiro Tanaka, Ichiro Kojima and Toshiro Fujita

Polymorphisms of the Aldose Reductase Gene and Susceptibility to Diabetic Microvascular Complications

Journal: Current Medicinal Chemistry
Volume: 10, Issue: 15
Page: 1389-1398
Authors: A. G. Demaine

The Role of 5-AMP-Activated Protein Kinase (AMPK) in Diabetic Nephropathy: A New Direction?

Journal: Current Enzyme Inhibition
Volume: 5, Issue: 1
Page: 44-50
Authors: K. Wyatt McMahon, Dora I. Zanescu, Vineeta Sood, Elmus G. Beale and Sharma S. Prabhakar

Chemopreventive Properties and Molecular Mechanisms of the Bioactive Compounds in Hibiscus Sabdariffa Linne

Journal: Current Medicinal Chemistry
Volume: 18, Issue: 8
Page: 1245-1254
Authors: Hui-Hsuan Lin, Jing-Hsien Chen and Chau-Jong Wang

Renin-angiotensin System Blockade at the Level of the Angiotensin Converting Enzyme or the Angiotensin Type-1 Receptor: Similarities and Differences

Journal: Current Topics in Medicinal Chemistry
Volume: 4, Issue: 4
Page: 473-481
Authors: George S. Stergiou and Irini I. Skeva

Jak2 and Reactive Oxygen Species: A Complex Relationship

Journal: Current Chemical Biology
Volume: 1, Issue: 3
Page: 303-310
Authors: Issam McDoom and Peter P. Sayeski

Building a Bridge Between Clinical and Basic Research: The Phenotypic Elements of Familial Predisposition to Type 1 Diabetes

Journal: Current Medicinal Chemistry
Volume: 14, Issue: 5
Page: 555-567
Authors: E. Matteucci and O. Giampietro

Pathogenesis and Treatment of Type 2 Diabetic Nephropathy: Lessons from the Spontaneous KK/Ta Mouse Model

Journal: Current Diabetes Reviews
Volume: 1, Issue: 3
Page: 281-286
Authors: Yasuhiko Tomino, Mitsuo Tanimoto, Toshihide Shike, Kenji Shiina, Qiuling Fan, Jie Liao, Tomohito Gohda, Yuichiro Makita and Kazuhiko Funabiki

Insight on the Pathogenesis of Diabetic Nephropathy from the Study of Podocyte and Mesangial Cell Biology

Journal: Current Diabetes Reviews
Volume: 1, Issue: 1
Page: 27-40
Authors: Gabriella Gruden, Paolo C. Perin and Giovanni Camussi